Search research articles
Contact Us
Filters
Showing results (151-160 of 159) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 159 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2002
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules
A Awada, S Giacchetti, B Gerard, et al.
British Journal of Cancer
|
February 23, 1999
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen
J N Primrose, H Bleiberg, F Daniel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group
T Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group
H Bleiberg, G Decoster, A de Gramont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
U Vanhoefer, P Rougier, H Wilke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
C-H Köhne, J De Greve, J T Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 1999
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)
E Van Cutsem, D Cunningham, W W Ten Bokkel Huinink, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials
F Bonnetain, C Borg, R R Adams, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 159) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 159 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 28, 2002
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules
A Awada, S Giacchetti, B Gerard, et al.
British Journal of Cancer
|
February 23, 1999
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen
J N Primrose, H Bleiberg, F Daniel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group
T Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group
H Bleiberg, G Decoster, A de Gramont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
U Vanhoefer, P Rougier, H Wilke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 11, 2007
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
C-H Köhne, J De Greve, J T Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 1999
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)
E Van Cutsem, D Cunningham, W W Ten Bokkel Huinink, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 22, 2017
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials
F Bonnetain, C Borg, R R Adams, et al.
Page
of 16